Exfoliative dermatitis - Dermatite Esfoljattiva
☆ AI Dermatology — Free Service
Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Red (burning) Skin Syndrome ― Eritema u skala fuq il-ġisem kollu huma s-sintomi ewlenin ta' Dermatite Esfoljattiva (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesErythroderma hija kundizzjoni tal-ġilda rari iżda serja. Filwaqt li l‑kawża eżatta ħafna drabi mhix magħrufa, tista’ tiġi attivata minn reazzjoni għal mediċina jew kanċer sottostanti. Kanċer wieħed komuni marbut mad‑dermatite esfoljattiva hija l‑limfoma taċ‑ċelluli T tal‑ġilda (cutaneous T‑cell lymphoma), li tista’ ma turix sintomi għal xhur jew saħansitra snin wara li tibda l‑kundizzjoni tal‑ġilda. Normalment, l‑isptar hija meħtieġa għall‑valutazzjoni u t‑trattament inizjali. Pazjenti b’mard ikkawżat mid‑droga ġeneralment ikollhom prospetti tajba fit‑tul, għalkemm każijiet mingħajr kawża ċara għandhom it‑tendenza li jkollhom kors rikorrenti u remittenti. Il‑pronżi għal każijiet marbuta mal‑kanċer tipikament tiddependi fuq kif il‑kanċer jimxi ’l quddiem.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Tipikament juri ħmura mifruxa u tqattigħ li jkopri aktar minn 90% tal-ġisem. Din il-kundizzjoni hija sinjal viżibbli ta’ diversi kwistjonijiet ta’ saħħa sottostanti bħal psorjasi, ekżema, jew reazzjoni għal ċerti mediċini.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
L-aktar kawża komuni ta' eritroderma (erythroderma) hija aggravament ta' marda tal-ġilda sottostanti, bħal psorjasi (psoriasis), dermatite tal-kuntatt (contact dermatitis), dermatite seborrheic (seborrheic dermatitis), lichen planus, pityriasis rubra pilaris jew reazzjoni ta' mediċina (drug reaction), bħall-użu ta' sterojdi topiċi (topical steroids). Il-manefestazzjoni primarja hija inqas frekwenti u ġeneralment tidher f'każijiet ta' limfoma taċ-ċelluli T tal-ġilda (cutaneous T‑cell lymphoma). Minħabba li huwa importanti li tiġi differenzjata mil-limfoma taċ-ċelluli T tal-ġilda, issir bijopsija (biopsy).